Antiinflammatory mechanisms are important in ovulation and may be regulated by cortisol (F). We previously showed that after administration of human (h)CG for ovulation induction, luteinized granulosa cells (LGC) abundantly express 11␤-hydroxysteroid dehydrogenase type 1 (11␤HSD1) messenger RNA but not 11␤HSD type 2 (11␤HSD2) messenger RNA. 11␤HSD1 is responsible for the reversible formation of antiinflammatory F from its inactive precursor cortisone (E), whereas 11␤HSD2 unidirectionally converts F to E through 11-oxidation. This pattern of gene expression predicts that
M AMMALIAN OVULATION HAS been described as a controlled inflammatory event (1) . Proteolytic degeneration of the follicle wall and ovarian surface, culminating in the release of a fertilizable egg, is followed by rapid resolution of the inflammatory reaction and repair of the ovarian surface in anticipation of the next ovulatory sequence. Delineating the cellular and molecular mechanisms through which this injury-repair process is mediated is fundamental to our ability to manipulate ovarian function in health and disease.
Cortisol (F) has well-established antiinflammatory properties (2, 3) . It has been proposed that locally activated glucocorticoid production may play a role in limiting tissue damage and mediating repair/remodeling after human ovulation (4, 5) . One evidence for this proposal comes from the finding of elevated total F concentration in follicular fluid relative to that in serum close to follicular rupture (5) . Additionally, the proinflammatory cytokines tumor necrosis factor-␣ and interleukin-1␤ were recently reported to stimulate the expression of 11␤-hydroxysteroid dehydrogenase type 1 (11␤HSD1) messenger RNA (mRNA) in glomerular mesangial cells (6) and rat granulosa cells (7) in vitro. Because 11␤HSD1 promotes reversible formation of F from cortisone (E), we interpret this as evidence that the proinflammatory cascade that leads to ovulation induces a compensatory antiinflammatory response in the ovary, which includes upregulation of 11␤HSD1 and increased local availability of F.
The two known isozymes of 11␤HSD are present in the human ovary, where their expression is developmentdependent (8) . Granulosa cells of immature follicles (IGC) express predominantly 11␤HSD type 2 (11␤HSD2) mRNA. In contrast, luteinized granulosa cells (LGC) in periovulatory follicles, after human (h)CG administration to induce ovulation, express mainly 11␤HSD1 mRNA but little or no 11␤HSD2 mRNA. Because 11␤HSD2 has unidirectional dehydrogenase activity, converting F to its inactive 11-keto metabolite E, whereas 11␤HSD1 is bidirectional, tending to preferentially convert E to F in vivo (9) , this should result in enhanced production of F in periovulatory follicles, compared with immature follicles.
To test this hypothesis and thereby obtain further evidence for an antiinflammatory role for glucocorticoids in the ovary, it is necessary to measure E and F interconversion by ovarian cells directly. The aims of the present study were therefore: 1) to measure 11␤HSD enzymatic activity in IGC and LGC; 2) to measure follicular fluid levels of E and F in both immature and periovulatory follicles; 3) to determine whether 11␤HSD enzymatic activity is present in thecal cells (TC), which has hitherto not been reported; and 4) to determine whether granulosa cell 11␤HSD1 reductase activity (E-to-F conversion) is gonadotropically regulated in vitro.
Subjects and Methods Patients
Immature granulosa cells and TC were obtained from ovaries of women undergoing oophorectomy as part of their surgery for various benign gynecological conditions (Table 1) . These operations were performed before 1130 h. LGC were obtained by transvaginal ultrasoundguided aspiration of periovulatory follicles in patients undergoing in vitro fertilization (IVF)-embryo transfer cycles (Table 1) . IVF treatment was performed according to the standard long protocol of controlled ovarian stimulation (10) . Human CG (5,000 or 10,000 IU) (Profasi, Serono, Welwyn-Garden City, Herts, UK) was administered when there were at least three follicles Ն17-mm diameter, as determined by transvaginal ultrasonography. Oocyte recovery by follicular aspiration was performed 35 h after hCG administration. Blood samples for measurement of serum total E and F were obtained between 0830 h and 1030 h, approximately 1 h before surgery, in both groups of patients. All patients had given informed consent, and the project was approved by the local ethics committee.
Isolation of ovarian cells and follicular fluid
Resected ovaries were transported ice-cold to the laboratory and transferred to culture medium, which was also used for follicular dissection. The culture medium was Medium 199, containing Earle's salts, 25 mmol/L HEPES buffer, supplemented with 2 mmol/L l-glutamine, 50 IU/mL penicillin, 50 ng/mL streptomycin (all from Life Technologies, Inc., Paisley, Renfrewshire, UK) and 0.1% BSA (ICN Biomedicals, Inc., High Wycombe, Buckinghamshire, UK). With the aid of zoom stereomicroscopic optics, follicles were dissected free from surrounding stroma, and their diameters were measured using calipers (11) . IGC were gently scraped from the theca interna of hemisected follicles. All IGC from the same patient were pooled. Thecae from pooled follicles were rinsed in fresh medium and transferred to 2 mL of the same medium with added 0.1% collagenase type II from Cl. histolyticum and 0.01% deoxyribonuclease-I (both from Sigma, Poole, Dorset, UK). Complete dispersal into a cellular suspension was achieved by incubating the tissue in the enzyme solution for two successive 15-min periods, at 37 C, in a shaking water bath, with repeated pipetting after each incubation. Separated IGC and TC were sedimented by centrifugation at 800 ϫ g for 5 min and resuspended in fresh culture medium.
Follicular aspirates from IVF patients were obtained between 1000 h and 1130 h. They were transported ice-cold to the laboratory, where LGC were recovered by unit-gravity sedimentation and washed several times with Dulbecco's PBS until clear of red blood cells (12) . After centrifugation at 800 ϫ g for 5 min, granulosa cells were resuspended in fresh culture medium and counted.
Cell counting was performed in a hemocytometer using trypan blue exclusion to estimate viability, which ranged between 15-85%. Replicate portions of the cell suspensions, containing viable 1-5 ϫ 10 4 granulosa cells or 5 ϫ 10 4 TC, were then distributed into 24-well polystyrene culture dishes (Corning, Inc. Glass Works, Corning, NY) for measurement of 11␤HSD activity with or without culture, as described below.
Follicular fluid from individual antral follicles dissected from the ovarian specimens, and fluid from the first follicle aspirated at oocyte recovery were stored at Ϫ20 C for subsequent measurements of E, F, estradiol, and progesterone.
Measurement of 11␤HSD activity
Interconversion of [1,2,6,7- 3 H]E and [1,2,6,7-3 H]F was studied in all granulosa and TC preparations as an index of 11␤HSD activity, as previously described (10) . In brief, culture medium containing substrate E or F (50 pmol), including 0.1 Ci
, was added to each well to give a final vol of 0.5 mL. Control incubations containing no cells were also set up. All incubations were in triplicate. Incubation was for 4 h at 37 C in a humidified tissue culture incubator gassed with 95% air-5% CO 2 . Media from individual wells were then pipetted into glass tubes, to which was added diethyl ether (3 mL); and the samples were vortexed for 1 min. The extracts were transferred to tubes containing 10 L 10 Ϫ3 mol/L E and F. The dried etheric extracts were then transferred in ethyl acetate to silica gel-precoated plastic sheets (PE SIL G; Whatman Ltd., Maidstone, Kent, UK) for thin-layer chromatographic separation of precursor and product in the solvent system chloroform:ethanol (92:8 by vol) (BDH Laboratory Supplies, Poole, Dorset, UK). E and F bands were identified by visualization under UV light, and the corresponding areas were cut out and transferred to a scintillation counting vial for determination of radioactivity. Consistently greater than 90% of the total radioactivity added to the incubations was accounted for in the E and F bands. Enzymatic activity was expressed as percentage total radioactivity [(product cpm/substrate cpm ϩ product cpm)ϫ 100] after correction for values from control (no cell) incubations.
Effect of gonadotropins on 11␤HSD1 reductase activity in cell culture
In three cases (patients 6 -8; Table 1 ), IGC monolayers were established in the presence and absence of gonadotropins before determination of 11␤HSD activity. Serum precoated (13) culture wells, inoculated with replicate portions of IGC suspension (2-5 ϫ 10 4 viable cells per well), received additional medium containing gonadotropins, to give a total vol of 0.5 mL. The gonadotropins used were recombinant hFSH (3860 IU/mg) and LH (6850 IU/mg) donated by Ares-Serono, Geneva, Switzerland. Testosterone (10 Ϫ6 mol/L) was also added to the wells as an aromatase substrate. Incubation was for 48 h, at 37 C, under humidified 5% CO 2 . Spent medium was removed and stored at Ϫ20 C for 
Hormone assays
Total E and F were determined in serum and follicular fluid by RIA after high-performance liquid chromatography (HPLC) separation. After addition of epicortisol (11␣-hydroxy isomer of cortisol; 15 ng) as an internal standard for validation of HPLC peaks, the samples (up to 250 L) were partitioned with 10 vol cyclohexane:dichloromethane (95:5) to remove progesterone. The organic phase was discarded, and the sample was reextracted with ethyl acetate (1:10). The extract was then reduced to dryness under a stream of nitrogen at 60 C and reconstituted in HPLC mobile phase (acetonitrile:methanol:water, 15:25:60). Fractions containing E and F were collected, after separation by HPLC, with conditions as follows: C 18 Luna column (15 cm; internal diameter, 4.6 mm; pore size, 5 m; Phenomenex, Maccleçfield, Chesire, UK), 0.7 mL/min, 37 C. The fractions were reduced to half their volume, under nitrogen, as above and then extracted with ethyl acetate (5 mL). Suitable proportions of the dried extracts were then taken for RIA as previously described (14) . The inter-and intraassay precision (coefficient of variation) was less than 10%.
Estradiol and progesterone in serum, follicular fluid, and culture medium were measured by standard RIA using previously described methods (11, 15) . The inter-and intraassay coefficient of variation for each steroid was less than 12%.
Statistics
Statistical analysis was performed using Student's t test. Differences assigned a P value less than 0.05 were regarded as statistically significant. Correlations between follicular fluid and serum concentration of steroids were examined using linear regression analysis.
Results

Developmental variation in 11␤HSD activity
Interconversion of E and F. The overall pattern of E-F interconversion in patients 1-5 (IGC) and 9 -15 (LGC) ( Table 1) was consistent with a markedly higher level of 11␤HSD1 reductase activity in LGC, as compared with IGC. The converse was true for dehydrogenase activity, which was higher in IGC, compared with LGC. As illustrated in Fig. 1 , the percent conversion (mean Ϯ sem) of F to E was not measurably influenced by the stage of granulosa cell maturity (31.0 Ϯ 2.9 in LGC vs. 41.7 Ϯ 7.4 in IGC; P ϭ 0.15). In contrast, percent conversion of E to F by LGC was over 60-fold greater than that of IGC (36.3 Ϯ 3.7 vs. 0.6 Ϯ 0.4; P Ͻ 0.001). In LGC, the percent conversion of E to F consistently exceeded that of the reverse reaction, although the difference was not statistically significant. This is in keeping with the known predominant reductive role of 11␤HSD1 in vivo (9) . The high rate of F-to-E conversion and negligible E-to-F conversion in IGC is consistent with a predominant 11␤HSD2 activity in these cells. TC from immature follicles (patients 1-5) revealed minimal conversion of E to F (0.2 Ϯ 0.1%), with a significantly higher, but low-level (4.7 Ϯ 0.9%), conversion of F to E (P Ͻ 0.005) (Fig. 1) .
Follicular fluid and serum E and F levels. Follicular fluid levels
of total E and F and F:E ratios in both immature and periovulatory follicles are presented in Fig. 2 . The mean (Ϯsem) concentration of F was significantly higher in periovulatory follicles (n ϭ 10) that yielded LGC, compared with immature follicles (n ϭ 15) that yielded IGC (254.8 Ϯ 39.1 vs. 153.7 Ϯ 20.0 nmol/L; P Ͻ 0.05). The converse was true for E, the level being higher in immature follicles than periovulatory follicles (76.2 Ϯ 7.9 vs. 41.9 Ϯ 5.2 nmol/L; P Ͻ 0.01). The F:E ratios were significantly greater in follicular fluid from periovulatory follicles (6.2 Ϯ 0. 
FIG. 2. Follicular fluid concentrations of E and F (nmol/L)
, and F:E ratios in individual immature (antral, E; n ϭ 15 from 6 patients) and periovulatory (IVF, ‚) follicles (n ϭ 10 from 10 patients), with group means depicted by horizontal bars. In periovulatory follicles, the levels of F and the F:E ratios were significantly higher (P Ͻ 0.05 and P Ͻ 0.001, respectively), and the levels of E were significantly lower (P Ͻ 0.01), than the corresponding values in immature follicles.
patients (116.7 Ϯ 20.1 nmol/L), the difference was not statistically significant. Linear regression analysis revealed no correlation between follicular fluid and serum concentrations of F in the IVF patients (r ϭ 0.08; P ϭ 0.83). A similar lack of correlation was obtained between E in follicular fluid of immature follicles and serum (r ϭ 0.09; P ϭ 0.81).
Concentrations of estradiol and progesterone measured in follicular fluid confirmed the classification of granulosa cell maturity. Thus, the mean (Ϯsem) estradiol level in periovulatory follicles was 1081.5 Ϯ 188.9 nmol/L; and in immature follicles, it was 65.5 Ϯ 16.4 nmol/L. The progesterone level was 58.0 Ϯ 5.9 mol/L in follicular fluid from periovulatory follicles and 0.4 Ϯ 0.1 mol/L in immature follicles.
Gonadotropic regulation of 11␤HSD1 reductase activity in vitro
In three of three cases, treatment of IGC cultures with hFSH significantly increased the percent conversion of E to F, relative to untreated controls (Fig. 3) . In two of these cases (patients 6 and 7), hFSH also stimulated aromatase activity (estradiol production) and progesterone production (Fig. 3,  A and B) , but neither of them showed a significant response to hLH. The third case (patient 8) responded to hLH in the same way as hFSH, with significantly increased percent conversion of E to F and progesterone production but not aromatase activity (Fig. 3C) .
Discussion
Here we show that LGC develop an increased capacity to convert E to F, leading to intrafollicular accumulation of total F as ovulation approaches. This is in keeping with the dramatic switch from 11␤HSD2 to 11␤HSD1 gene expression that hCG administration has been shown to induce in human granulosa cells (8) . The crucial point is that this switch in 11␤HSD isozyme expression is faithfully mirrored in the type and level of 11␤HSD enzymatic activity in IGC and LGC. Measurement of total F probably underestimates the difference between the follicular fluid levels of free, biologically active F in immature and periovulatory follicles. This is because the high level of progesterone in follicular fluid at the time of ovulation and the high affinity of progesterone for cortisol-binding protein are thought to displace F from cortisol-binding protein, thereby increasing the fraction of free F in follicular fluid, relative to that in serum (5) . Because follicular fluid from immature follicles contain much lower levels of progesterone than follicular fluid from periovulatory follicles, the fraction of free F would be expected to be correspondingly less.
Our results therefore suggest the existence of an E-F shuttle (16) in the ovary, similar to other glucocorticoid target tissues in which 11␤HSD activity gates the access of F to glucocorticoid receptors. However, in contrast to the constitutive expression of one or other 11␤HSD isozyme in other   FIG. 3 . Effects of recombinant human gonadotropins on percent conversion of E to F, and production of estradiol (E 2 ) and progesterone (P) by granulosa cells from immature antral follicles (IGC). Bars, Mean Ϯ SEM values of triplicate determinations. IGC monolayers were cultured for 48 h in the presence of hFSH (10 ng/mL) or hLH (10 ng/mL), followed by standard 4-h incubations with [ 3 H]E. Vertical bar C, Control experiments without added gonadotropins; L, LH treatment; F, FSH treatment. a (P Յ 0.001) and b (P Ͻ 0.05) denote statistically significant differences between treatment groups and the corresponding control experiments. A and B, Results from patients 6 and 7, respectively; C, results from patient 8. In contrast to the findings in A and B, this shows a significant stimulatory effect of hLH, as well as hFSH, on conversion of E to F and progesterone production by IGC. Granulosa cells from a large follicle (15 mm) with estradiol (1500 nmol/L) and progesterone (18.0 mol/L) levels in the late preovulatory range were among the pool of cells that were studied in this experiment, possibly explaining the response to hLH. The high basal aromatase activity, resulting in complete metabolism of substrate testosterone to estradiol in control incubations, explains the inability of these IGC monolayers to increase estradiol synthesis in response to either hFSH or hLH.
tissues, the ovary expresses both isozymes. While two studies to date have reported increased follicular fluid levels of F after the midcycle LH surge (17) or hCG injection (5), only one study has measured E in addition to F (18) . This study reported concentrations of follicular fluid F similar to ours, and the F:E ratio was also greater in IVF periovulatory follicles (post-hCG), compared with follicles just before hCG administration. However, the latter group of patients all had polycystic ovarian syndrome and had received gonadotropin stimulation before follicle aspiration. They were therefore dissimilar to our patients in whom the immature follicles were studied. This is an important difference because serum levels of F and urinary excretion of F metabolites have been reported to be increased in polycystic ovarian syndrome (19, 20) . Another major difference is that Andersen et al. (18) did not measure granulosa cell 11␤HSD activity.
It may be argued that the higher concentration of F in periovulatory follicles was attributable to higher stress levels in the IVF patients, because their serum F levels were also higher than those of patients undergoing elective gynecological surgery. However, if this was true, follicular fluid E should also have increased in parallel with F. On the contrary, we found the level of follicular fluid E to be significantly higher in immature follicles than periovulatory follicles. This is compatible with the predominance of 11␤HSD2 mRNA (8) and enzymatic activity in IGC. Additionally, there was no correlation between the levels of F in serum and follicular fluid in the IVF patients. It is not known whether the diurnal variation of glucocorticoid levels in blood also occurs in follicular fluid. However, all the blood samples and follicular fluid aspirates were collected in the morning. This would minimize any confounding influence caused by a diurnal variation in follicular fluid glucocorticoid levels.
Adrenal glucocorticoids can affect ovarian function through central inhibition of pituitary gonadotropin production (21) , which is thought to explain the association of anovulation with stress and clinical states of glucocorticoid excess. At the ovarian level, the role of glucocorticoid metabolism presumably reflects the classic glucocorticoid actions in response to altered states of nutrition, injury, or stress seen elsewhere in the body. The present demonstration of increased intrafollicular F, in relation to ovulation, most obviously suggests involvement with final oocyte maturation and/or follicular rupture, but this remains to be determined. Fateh et al. (22) reported a positive correlation between oocyte maturity and follicular fluid levels of F. Cortisol metabolism by cultured LGC in vitro has been correlated with IVF outcome (23), but such a relationship was not observed when freshly isolated LGC were studied (10) . Mice that survive to adulthood with inactivating11␤HSD1 (24) or 11␤HSD2 (25) mutations can reproduce. However, the ability to reproduce does not indicate unimpaired fecundity, because ovarian phenotypes and reproductive performance in these knockout animals have not been addressed in detail. On the other hand, the relative abundance of E in the follicular fluid of immature follicles and the almost exclusive expression of 11␤HSD2 mRNA and activity in IGC may imply a protective mechanism against the excessive accumulation of F in developing antral follicles, as in the case of the kidney (26, 27) and possibly placenta (28, 29) .
Experiments with rat granulosa cells have shown that treatment with LH induces a switch from 11␤HSD2 to 11␤HSD1 expression in vivo and in vitro (7, 30) . However, this only occurred when the cells were first exposed to sufficient amounts of FSH to induce LH receptors and LH responsiveness. In the present study of human granulosa cells, we found consistent up-regulation of 11␤HSD1 activity by hFSH, but not hLH, in vitro. However, the exception proved the rule, because IGC from patient 8 (Fig. 3C) , which responded to hLH as well as hFSH, included cells from a relatively mature (15-mm diameter) follicle with follicular fluid estradiol (1500 nmol/L) and progesterone (18.0 mol/L) in the late preovulatory range. Although the contribution of granulosa cells from this follicle to the overall hLH effect is not known, the responsiveness to hLH, in terms of 11␤HSD1 activity as well as progesterone synthesis, is consistent with advanced preovulatory status. The inability of the same cells to increase aromatase activity in the presence of hFSH or hLH can be explained by the high basal aromatase activity that they displayed, leading to exhaustion of substrate testosterone in the culture medium, even in the absence of exogenous gonadotropins.
Low-level 11␤HSD2 activity was also present in TC from immature follicles. Similar to IGC, TC showed negligible 11␤HSD1 activity. This corroborates the work of Ricketts et al. (31) , which showed positive immunocytochemical staining with the type 2, but not type 1, 11␤HSD antibody in follicular phase thecal and granulosa cells. Whether the midcycle LH surge or hCG administration modulates 11␤HSD activity in TC as ovulation approaches is not known, because TC from periovulatory follicles were unavailable for study. Moreover, the ability of gonadotropins to up-regulate granulosa cell 11␤HSD activity in vitro does not rule out the possibility that paracrine mechanisms emanating from TC contribute to this effect in vivo. Indeed, the potential for paracrine modulation of 11␤HSD activity in hLGC has previously been highlighted (32) .
In conclusion, our findings provide direct evidence for a development-related switch in the expression of 11␤HSD1 and 2 enzymatic activity in human granulosa cells, favoring formation of F as ovulation approaches. We also show, for the first time, that 11␤HSD activity is gonadotropically regulated in human granulosa cells and present in TC. Overall, these results strengthen the case for a physiological role of 11␤HSD and its regulation of intrafollicular glucocorticoid metabolism in the human ovary. The role of glucocorticoids in ovulation remains unknown. However, in view of the inflammatory nature of ovulation and the potent antiinflammatory effects of cortisol, our findings are consistent with the hypothesis that glucocorticoids have a local antiinflammatory role, mediating repair and healing of the ovary before the next ovulatory process.
